Literature DB >> 3778498

An animal model of iron overload and its application to study hepatic ferritin iron mobilization by chelators.

A Longueville, R R Crichton.   

Abstract

Administration of 3,5,5-trimethylhexanoyl ferrocene in the diet of male Wistar rats results in a substantial increase in hepatic ferritin protein (greater than 2-fold) and of ferritin iron (4-8-fold). The iron-loading in liver, under the conditions used, appears to be essentially in parenchymal cells rather than in reticulo-endothelial cells. It is suggested that the model represents a useful system for the study of the potential efficacy of new iron chelators for the mobilization of hepatic storage iron. The ability of desferal (DFO) and of a new siderophore, desferrithiocin (DFT), to mobilize hepatic ferritin iron is observed in this model of iron overload. Desferrithiocin stimulates ferritin iron mobilization, when administered either by gavage or by intraperitoneal injection, whereas desferal is active intraperitoneally but inactive orally. Our studies lead to the conclusion that DFT merits further examinations, for its activity as an orally active iron chelator.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3778498     DOI: 10.1016/0006-2952(86)90650-7

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  5 in total

1.  Role of oxidants in DNA damage. Hydroxyl radical mediates the synergistic DNA damaging effects of asbestos and cigarette smoke.

Authors:  J H Jackson; I U Schraufstatter; P A Hyslop; K Vosbeck; R Sauerheber; S A Weitzman; C G Cochrane
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

2.  Desferrithiocin is a more potent antineoplastic agent than desferrioxamine.

Authors:  Anthony Kicic; Anita C G Chua; Erica Baker
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

3.  Accumulation of iron by primary rat hepatocytes in long-term culture: changes in nuclear shape mediated by non-transferrin-bound forms of iron.

Authors:  E E Cable; J R Connor; H C Isom
Journal:  Am J Pathol       Date:  1998-03       Impact factor: 4.307

Review 4.  The Efficacy of Iron Chelators for Removing Iron from Specific Brain Regions and the Pituitary-Ironing out the Brain.

Authors:  Robert R Crichton; Roberta J Ward; Robert C Hider
Journal:  Pharmaceuticals (Basel)       Date:  2019-09-17

Review 5.  Is Chelation Therapy a Potential Treatment for Parkinson's Disease?

Authors:  Roberta J Ward; David T Dexter; Antonio Martin-Bastida; Robert R Crichton
Journal:  Int J Mol Sci       Date:  2021-03-24       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.